After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Supernus Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Supernus Pharmaceuticals Inc is $2.65B. A total of 0.73 million shares were traded on the day, compared to an average of 820.55K shares.
In the most recent transaction, Khattar Jack A. sold 29,513 shares of SUPN for 47.23 per share on Sep 23 ’25. After the transaction, the President, CEO now owns 1,140,883 company shares. In a previous transaction on Sep 22 ’25, Khattar Jack A. sold 16,587 shares at 47.02 per share. SUPN shares that President, CEO owns now total 1,122,456.
Among the insiders who bought shares, JACK A. KHATTAR acquired of 29,513 shares on Sep 23 ’25 at a per-share price of $46.98. In another insider transaction, JACK A KHATTAR bought 16,587 shares at $46.04 per share on Sep 22 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SUPN has a high of $47.65 and a low of $29.16.
As of this writing, SUPN has an earnings estimate of $0.29 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of $0.34 per share and a lower estimate of $0.26. The company reported an EPS of $1.1 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SUPN’s latest balance sheet shows that the firm has $339.68M in Cash & Short Term Investments as of fiscal 2021. There were $427.03M in debt and $315.38M in liabilities at the time. Its Book Value Per Share was $18.96, while its Total Shareholder’s Equity was $815.85M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SUPN is Buy with a score of 4.33.
